A pilot study of carboplatin augmentation therapy for patients with poor risk acute non-lymphocytic leukemia

This publication has 10 references indexed in Scilit:

• Use of the day 6 bone marrow to alter remission induction therapy in patients with acute myeloid leukaemia: a leukemia intergroup study
  British Journal of Haematology, 1989
• Infusion carboplatin treatment of relapsed and refractory acute leukemia: evidence of efficacy with minimal extramedullary toxicity at intermediate doses.
  Journal of Clinical Oncology, 1989
• Day 4 bone marrow aspirate for prediction of resistance to induction chemotherapy in acute myeloid leukemia
  Leukemia Research, 1987
• Classifying acute leukemia by immunophenotyping: a combined FAB- immunologic classification of AML
  Blood, 1986
• Prediction of response of acute nonlymphocytic leukaemia to therapy with ‘high dose’ cytosine arabinoside
  British Journal of Haematology, 1984
• Recognition of drug resistance during remission induction therapy for acute non-lymphocytic leukemia: Utility of day 6 bone marrow biopsy
  Leukemia Research, 1983
• Early clinical studies with cis-diammine-1,1-cyclobutane dicarboxylate platinum II
  Cancer Chemotherapy and Pharmacology, 1982
• Advances in the Treatment of Acute Myelogenous Leukemia
  New England Journal of Medicine, 1979
• Treatment of acute nonlymphocytic leukemia: use of anthracycline- cytosine arabinoside induction therapy and comparison of two maintenance regimens
  Blood, 1979
• Remission induction in acute nonlymphocytic leukemia: Comparison of a seven‐day and ten‐day infusion of cytosine arabinoside in combination with adriamycin
  Medical and Pediatric Oncology, 1979